sensus healthcare inc - SRTS

SRTS

Close Chg Chg %
4.49 -0.03 -0.67%

Open Market

4.46

-0.03 (0.67%)

Volume: 6.80K

Last Updated:

Apr 15, 2026, 3:12 PM EDT

Company Overview: sensus healthcare inc - SRTS

SRTS Key Data

Open

$4.53

Day Range

4.37 - 4.53

52 Week Range

3.03 - 5.92

Market Cap

$73.91M

Shares Outstanding

16.46M

Public Float

14.76M

Beta

1.28

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.47

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

39.07K

 

SRTS Performance

1 Week
 
0.00%
 
1 Month
 
15.42%
 
3 Months
 
-15.28%
 
1 Year
 
-2.18%
 
5 Years
 
22.68%
 

SRTS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 4
Full Ratings ➔

About sensus healthcare inc - SRTS

Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.

SRTS At a Glance

Sensus Healthcare, Inc.
851 Broken Sound Parkway North West
Boca Raton, Florida 33487
Phone 1-561-922-5808 Revenue 27.48M
Industry Medical Specialties Net Income -7,719,000.00
Sector Health Technology Employees 60
Fiscal Year-end 12 / 2026
View SEC Filings

SRTS Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 2.365
Price to Book Ratio 1.362
Price to Cash Flow Ratio 123.07
Enterprise Value to EBITDA -4.48
Enterprise Value to Sales 1.578
Total Debt to Enterprise Value 0.011

SRTS Efficiency

Revenue/Employee 458,033.333
Income Per Employee -128,650.00
Receivables Turnover 4.549
Total Asset Turnover 0.477

SRTS Liquidity

Current Ratio 9.719
Quick Ratio 6.312
Cash Ratio 4.677

SRTS Profitability

Gross Margin 43.181
Operating Margin -37.505
Pretax Margin -35.019
Net Margin -28.087
Return on Assets -13.397
Return on Equity -14.855
Return on Total Capital -15.893
Return on Invested Capital -14.769

SRTS Capital Structure

Total Debt to Total Equity 0.979
Total Debt to Total Capital 0.97
Total Debt to Total Assets 0.888
Long-Term Debt to Equity 0.435
Long-Term Debt to Total Capital 0.43
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Sensus Healthcare Inc - SRTS

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
44.53M 24.41M 41.81M 27.48M
Sales Growth
+64.68% -45.20% +71.31% -34.26%
Cost of Goods Sold (COGS) incl D&A
14.90M 10.35M 17.38M 15.62M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
315.00K 412.00K 432.00K 626.00K
Depreciation
219.00K 412.00K 432.00K 626.00K
Amortization of Intangibles
- - - 96.00K
-
COGS Growth
+48.24% -30.59% +67.97% -10.13%
Gross Income
29.63M 14.06M 24.43M 11.87M
Gross Income Growth
+74.41% -52.54% +73.76% -51.43%
Gross Profit Margin
+66.53% +57.61% +58.44% +43.18%
2022 2023 2024 2025 5-year trend
SG&A Expense
14.80M 14.44M 16.34M 22.17M
Research & Development
3.46M 3.68M 4.22M 7.78M
Other SG&A
11.34M 10.76M 12.13M 14.40M
SGA Growth
+14.99% -2.40% +13.15% +35.70%
Other Operating Expense
- - - -
-
Unusual Expense
- - - -
-
EBIT after Unusual Expense
14.83M (382.00K) 8.09M (10.31M)
Non Operating Income/Expense
13.16M 1.03M 932.00K 683.00K
Non-Operating Interest Income
382.00K 992.00K 932.00K 683.00K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - 2.00K
-
Interest Expense Growth
- - - -100.00%
-
Gross Interest Expense
- - - 2.00K
-
Interest Capitalized
- - - -
-
Pretax Income
27.99M 652.00K 9.02M (9.62M)
Pretax Income Growth
+579.53% -97.67% +1,283.74% -206.67%
Pretax Margin
+62.85% +2.67% +21.58% -35.02%
Income Tax
3.75M 167.00K 2.38M (1.91M)
Income Tax - Current - Domestic
1.95M 594.00K 2.43M (24.00K)
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
1.85M (427.00K) (57.00K) (1.88M)
Income Tax - Deferred - Foreign
- - - (55.00K)
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
24.24M 485.00K 6.65M (7.72M)
Minority Interest Expense
- - - -
-
Net Income
24.24M 485.00K 6.65M (7.72M)
Net Income Growth
+488.59% -98.00% +1,270.52% -216.13%
Net Margin Growth
+54.44% +1.99% +15.90% -28.09%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
24.24M 485.00K 6.65M (7.72M)
Preferred Dividends
- - - -
-
Net Income Available to Common
24.24M 485.00K 6.65M (7.72M)
EPS (Basic)
1.471 0.0298 0.4075 -0.4728
EPS (Basic) Growth
+488.40% -97.97% +1,267.45% -216.02%
Basic Shares Outstanding
16.48M 16.26M 16.31M 16.33M
EPS (Diluted)
1.4589 0.0298 0.4063 -0.4728
EPS (Diluted) Growth
+484.50% -97.96% +1,263.42% -216.37%
Diluted Shares Outstanding
16.62M 16.27M 16.36M 16.33M
EBITDA
15.15M 30.00K 8.52M (9.68M)
EBITDA Growth
+220.01% -99.80% +28,306.67% -213.60%
EBITDA Margin
+34.01% +0.12% +20.38% -35.23%

Snapshot

Average Recommendation BUY Average Target Price 6.667
Number of Ratings 4 Current Quarters Estimate -0.085
FY Report Date 06 / 2026 Current Year's Estimate -0.263
Last Quarter’s Earnings -0.115 Median PE on CY Estimate N/A
Year Ago Earnings -0.47 Next Fiscal Year Estimate 0.048
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 4 4 4 4
Mean Estimate -0.09 -0.05 -0.26 0.05
High Estimates -0.04 0.00 -0.08 0.32
Low Estimate -0.15 -0.10 -0.50 -0.13
Coefficient of Variance -54.76 -87.94 -67.32 403.63

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 4 4 3
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Sensus Healthcare Inc - SRTS

Date Name Shares Transaction Value
Dec 18, 2025 Michael J. Sardano PRESIDENT AND GENERAL COUNSEL; Director 158,839 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Nov 21, 2025 Eric Sachetta Director 133,113 Open market or private purchase of non-derivative security Non-derivative transaction at $4.5 per share 599,008.50

Sensus Healthcare Inc in the News